Overall rank by patents
#26,015
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
According to USPTO PatentsView, Clear ranks #26,015 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.
USPTO PatentsView assignee plate
Corpus R26015 · US Corporation #26,015 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Clarcor Air Filtration Products, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Clear Labs · this assignee
41 score
3D Lighting Innovati… · lowest
7 score
What this shows Clear's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Clear Labs, Inc is a focused PatentsView assignee: 8 CPC subclasses with 90% of grants classified under C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2019. By volume, Clear sits between Clarvista Medical, Inc. and Cloudpassage, Inc..
Clear Labs, Inc shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ClarVista Medical, Inc.
10 patents
Clarcor Air Filtration Products, Inc.
10 patents
Claussen Technology, LLC
10 patents
Clean Hands Safe Hands LLC
10 patents
ClearingBid, Inc.
10 patents
Cleveland BioLabs, Inc.
10 patents
Cloud Dx, Inc.
10 patents
CloudPassage, Inc.
10 patents
Clear Labs, Inc
10 patents
What this shows Clear holds 10 patents at rank #26,046, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,046 in granted patent volume.
Other assignees with the most granted patents in Clear's primary technology class.
Clear's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 20.0% |
| 2019 | 1 | 10.0% |
| 2020 | 2 | 20.0% |
| 2022 | 2 | 20.0% |
| 2023 | 2 | 20.0% |
| 2025partial year | 1 | 10.0% |
Top 8 of 8 technology areas
Overall rank by patents
#26,015
of 50,000 tracked assignees
40.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.